Anúncio
Anúncio

CAMP

CAMP logo

CAMP4 Therapeutics Corporation Common Stock

6.19
USD
Patrocinado
-0.01
-0.23%
08 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

6.21

+0.02
+0.39%

Relatórios de Lucros CAMP

Rácio de surpresa positiva

CAMP separação 2 de 5 últimas estimativas.

40%

Próximo Relatório

Data do Próximo Relatório
11 de mai. de 2026
Estimate for Q1 26 (Revenue/ EPS)
$306.00K
/
-$0.26
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-61.51%
/
-52.73%
Mudanças implicadas de Q1 25 (Revenue/ EPS)
-64.34%
/
-58.06%

CAMP4 Therapeutics Corporation Common Stock earnings per share and revenue

On 06 de nov. de 2025, CAMP reported earnings of -0.55 USD per share (EPS) for Q3 25, missing the estimate of -0.48 USD, resulting in a -12.73% surprise. Revenue reached 795.00 mil, compared to an expected 530.40 mil, with a 49.89% difference. The market reacted with a -4.49% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analistas forecast an EPS of -0.26 USD, with revenue projected to reach 306.00 mil USD, implying an diminuir of -52.73% EPS, and diminuir of -61.51% in Revenue from the last quarter.
FAQ
For Q3 2025, CAMP4 Therapeutics Corporation Common Stock reported EPS of -$0.55, missing estimates by -12.73%, and revenue of $795.00K, 49.89% above expectations.
The stock price moved down -4.49%, changed from $4.45 before the earnings release to $4.25 the day after.
The next earning report is scheduled for 11 de mai. de 2026.
Based on 5 analistas, CAMP4 Therapeutics Corporation Common Stock is expected to report EPS of -$0.26 and revenue of $306.00K for Q1 2026.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio